ThermoGenesis Holdings, Inc. (OTCPK:THMO) Q2 2020 Earnings Conference Call August 14, 2020 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings' Conference Call and Webcast to Review Financial and Operating Results for the Second Quarter Ended June 31, 2020. As a reminder, all participant ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2020. or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition from _____________ to _______________. Commission File Number: 333-82900 ThermoGenesis Holdings, Inc. (Exact name of registrant as specified in its charter) Delawar ...

—— A leader in cellular processing "A solution provider for automated cell processing tools and services in the cell & gene therapy field" A Corporate Update in the Fight against COVID-19 May 14, 2020 © 2020 ThermoGenesis Holdings, Inc. (NASDAQ:THMO) 2 Disclosure and Forward-Looking Statement This presentation includes statements of future expectations and other forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statem ...

ThermoGenesis Holdings, Inc. (OTCPK:THMO) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chairman and CEO Jeff Cauble - CFO Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings' Conference Call and Webcast to Review Financial and Operating Results for the First Quarter Ended March 31, 2020. [Operator Instructions] As a reminder, today’s conference is ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2020. or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition from to . Commission File Number: 000-16375 ThermoGenesis Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 9 ...

ThermoGenesis Holdings, Inc. (OTCPK:THMO) Q4 2019 Results Earnings Conference Call March 24, 2020 4:30 AM ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chairman & Chief Executive Officer Jeff Cauble - Chief Financial Officer Operator Good day, and welcome to the ThermoGenesis Holdings' Conference Call and Webcast to review Financial and Operating Results for the Year-Ended December 31, 2019. As a reminder, all participants will be in listen-only mode. There will b ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-16375 THERMOGENESIS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 94-3018487 (I.R.S. Employer Iden ...

Cesca Therapeutics Inc. (NASDAQ:KOOL) is now ThermoGenesis Holdings, Inc. (NASDAQ:THMO) "A solution provider for automated cell processing tools and services in the cell & gene therapy field" Corporate Strategy Update Accompanying 2019Q3's Earning Call November 19, 2019 1 | Nasdaq:THMO 2 Disclosure and Forward Looking Statement This presentation includes statements of future expectations and other forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigat ...

ThermoGenesis Holdings, Inc. (OTCPK:THMO) Q3 2019 Results Earnings Conference Call November 19, 2019 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chairman & Chief Executive Officer Jeff Cauble - Vice President of Finance &Principal Accounting Officer Conference Call Participants Jason Kolbert - Dawson James Swayampakula Ramakanth - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings' Conference Call and Webcast to Review Financial ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q X Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2019. or ___ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition from _____________ to _______________. Commission File Number: 000-16375 ThermoGenesis Holdings, Inc. (formerly known as Cesca Therapeutics Inc.) (Exact name ...